Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantationMichaela Döring, Ingo Müller, Peter Lang et al.|BMC Infectious Diseases|2012Cited by 65
Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantationMichaela Döring, Ingo Müller, Olivia R. Blume et al.|European Journal of Clinical Microbiology & Infectious Diseases|2013Cited by 61
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropeniaMichaela Döring, Ingo Müller, R. Handgretinger et al.|European Journal of Clinical Microbiology & Infectious Diseases|2015Cited by 43